Amber Salzman, Epicrispr | theCUBE + NYSE Wired: MedTech Unplugged
SiliconANGLE theCUBE
Amber Salzman, CEO of EpiCrispr, introduces her company's groundbreaking approach to treating diseases through epigenetic editing, a technology that functions like software updates rather than hardware replacements. She explains that while DNA serves as the body's biological hardware, the epigenome …